Leukaemia Diagnostic Interpretation (LDI)
ACCREDITATION STATUS:
UKAS accredited - Proficiency testing provider No. 7804
This programme is operated by UK NEQAS Leucocyte Immunophenotyping. The centre provides flow cytometry and molecular haematology based programmes. For further information on the operation of the programme or details on current accreditation status please contact UK NEQAS Leucocyte Immunophenotyping directly.Email: admin@ukneqasli.co.uk
Telephone: +44 (0) 114 267 3600
CLINICAL APPLICATION:
Diagnosis of leukaemia
PURPOSE OF PROGRAMME:
This programme is designed to assess a laboratory's ability to diagnose leukaemia using a full spectrum of laboratory tests.
ANALYTES:
| Analyte | Default Unit |
|---|---|
| a detailed case history | Lineage, differentiation and diagnosis based on the WHO guidelines |
| a digitally scanned blood smear for morphological analysis | Lineage, differentiation and diagnosis based on the WHO guidelines |
| a full consensus phenotype (derived from the corresponding part one exercise) | Lineage, differentiation and diagnosis based on the WHO guidelines |
| cytogenetics | Lineage, differentiation and diagnosis based on the WHO guidelines |
| molecular genetics data and histology data if available | Lineage, differentiation and diagnosis based on the WHO guidelines |
MATERIAL PROVIDED: No samples are issued to participants. All information is provided electronically via the UK NEQAS LI website
DISTRIBUTIONS PER YEAR: Minimum 4; Maximum 6
SAMPLES PER DISTRIBUTION: One case is issued per distribution. No samples are issued to participants. This programme is web based
FREQUENCY OF DISTRIBUTION: Bimonthly as per Trial Schedule (Please note – The Trial Schedule is a guide only and is subject to change)
PROGRAMME OF ANALYSIS:
Results are entered online via the UK NEQAS LI website. Trials are live for 3 weeks. Results can be entered at any time during this period. Under exceptional circumstances late results are accepted at our discretion via email/fax.
DATA ANALYSIS:
Qualitative analysis based on the consensus diagnosis submitted by participants
PERFORMANCE MONITORING:
Participants are notified of their performance on the report
PERSISTENT POOR PERFORMANCE:
Participants are notified of their performance on the report
Leucocyte Immunophenotyping
LEUCOCYTE IMMUNOPHENOTYPING The External Quality Assessment Scheme for Leucocyte Immunophenotyping was established by Professor David Barnett in 1986 at Northern General Hospital, Sheffield. In 1990 the Service became known as the UK National External Quality Assessment Service for Leucocyte Immunophenotyping. UK NEQAS LI is part of the Sheffield Teaching Hospitals NHS Foundation Trust. The centre currently provides flow cytometry and molecular haematology based programmes. For the most up-to-date scheme information (including any pilot schemes) please contact the centre directly.
Contact Details
- 4th Floor Pegasus House
- 463a Glossop Road
- Sheffield
- S10 2QD
Leucocyte Immunophenotyping
- Telephone: +44 (0) 114 267 3600
- Fax: +44 (0) 114 267 3601
- Email: admin@ukneqasli.co.uk
- Web: http://www.ukneqasli.co.uk/